Journal of Pharmaceutical Analysis
Published by Xi'an Jiaotong University
ISSN : 2095-1779
Abbreviation : J. Pharm. Anal.
Aims & Scope
Journal of Pharmaceutical Analysis (JPA) is a peer-reviewed open access journal for original research articles, review articles and short communications related to all aspects of pharmaceutical analysis.
JPA was launched in 2011, and published bimonthly by Xi'an Jiaotong University.
This journal is indexed in SCIE, Scopus, PubMed Central, and DOAJ etc.
Current areas of interest include, but are not limited to: -Analysis of traditional Chinese medicine (medicinal materials, patent medicine, prescription, injection) -Pharmaceutical analysis of complex system -Quality control and methods of biotech drugs -Action mechanism and their metabolisms in body -Quantitative and qualitative analysis in the drug screening process -Tracer analysis in molecular pharmacology -Quantitative analysis in biopharmaceutics -Clinical laboratory and bioanalysis -Analysis of pharmacological activity -Analysis of drug toxicity -Analytical chemistry techniques and methods -New biochemistry methods for pharmaceutical analysis -Rapid screening methods -New analytical techniques and methods -Others: Pharmaceutical solid materials (including biomaterials, polymers and nanoparticles)Biotechnology products (including genes, peptides, proteins and vaccines)Engineered cells
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 8.9 |
Journal Rank
Year | Value |
---|---|
2024 | 2532 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 2599 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.452 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 60 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Chemistry, Health Professions and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Chemistry, Health Professions and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,850.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Methods for in vitro evaluating antimicrobial activity: A review
Citation: 4840
Authors: Mounyr, Moulay, Saad Koraichi
-
Molecular immune pathogenesis and diagnosis of COVID-19
Citation: 1119
Authors: Xiaowei, Manman, Yizhao, Liesu, Shemin
-
Development of forced degradation and stability indicating studies of drugs—A review
Citation: 675
Authors: M, Ruchi D., Prajesh N., Y.K.
-
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Citation: 663
Authors: Muhammad, Safar M., Mubarak A., Ling-Ling
-
Recent advances and perspectives of nucleic acid detection for coronavirus
Citation: 431
Authors: Minzhe, Ying, Jiawei, Abdu Ahmed, Yu, Su, Sheng
-
Research advances in the detection of miRNA
Citation: 354
Authors: Jiawei, Mingcheng, Xueke, Sheng, Su
-
Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin
Citation: 347
Authors: Vishwas D., Laxman S., Anil H., Prashant V., Govind B.
-
Application of microfluidic chip technology in pharmaceutical analysis: A review
Citation: 324
Authors: Ping, Sicen
-
Carbon nanotubes: Evaluation of toxicity at biointerfaces
Citation: 253
Authors: Debashish, Soma, Sanchit, Nilanjan